Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Tuberculosis

  • your selections
Clear Search

Filter Results

date

Tags

  • results
IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials

The following are stories from this week’s 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa: SciDev.Net: Steven Reid of the Imperial College London spoke of three prototype tests he and his colleagues have been working on that would help to increase access to CD4…

Prevention, Vaccines Addressed At IAS Conference

During the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa, scientists “renewed the call for more immediate and urgent effort to be directed towards HIV prevention amid the dominance of treatment interventions and the world-wide search for a quick fix vaccine, which many agree, is years away,” Health-e/allAfrica.com reports.

Camera-Phone Uses Blood, Saliva Samples To Diagnose Disease

Researchers at the University of California, Berkeley, have developed a “prototype camera-phone mounted with a microscope” that can “magnify and photograph blood or saliva samples” for diagnosing diseases, the Canadian Press/Google.com reports.

Also In Global Health News: Noncommunicable Disease Network; Tropical Disease Treatments; Maternal Health In Peru; South Asia MDG

WHO Launches International Network To Take On Noncommunicable Disease The WHO on Wednesday launched an international network of leading health organizations and experts from around the world in an effort to “unite” and “scal[e] up world action to combat noncommunicable diseases, which cause some 38 million deaths annually,” Xinhua/People’s Daily…

Global Fund-Financed Programs Reaching More People, Report Shows

The most recent statistics on programs funded in 140 countries through the Global Fund to Fight AIDS, Tuberculosis and Malaria released Wednesday reveal “[m]ore than 2 million people living with HIV have been reached with life-saving treatment,” the UN News Centre reports.

Op-Eds: Pharma In Africa; U.S. Global TB Funding; ITN Distribution Strategies Examined

Economic Crisis Presents Opportunity To Reform Pharmaceutical Practices In Africa, Says UNAIDS Head With an estimated 22 million people living with HIV in Africa, the demand for affordable and effective HIV/AIDS medications on the continent presents an opportunity to reform its pharmaceutical practices, Michel Sidibe, executive director of UNAIDS, writes…

U.S., Russia Sign Agreement To Cooperate On Health Goals

The White House announced on Monday that the U.S. and Russia have signed on to a “memo of understanding” to cooperate on several public health and medical science projects, ModernHealthcare.com reports.

Also In Global Health News: Potential New Drug-Resistant TB Treatment; HIV/AIDS Education; Interview With Assistant Secretary of State Carson; African Health Systems

Parkison’s Disease Drugs Could Treat MDR-TB, XDR-TB Researchers said “computer models and lab experiments suggest the drugs tolcapone or Tasmar made by Valeant Pharmaceuticals, and entacapone or Comtan made by Novartis AG [used to treat Parkinson's disease] have the potential to treat” multi-drug resistant tuberculosis and extensively drug-resistant TB, Reuters…